
Methodology: Every two weeks we collect most relevant posts on LinkedIn for selected topics and create an overall summary only based on these posts. If you´re interested in the single posts behind, you can find them here: https://linktr.ee/thomasallgeyer. Have a great read!
Posts say AI-powered triage systems increasingly outperform traditional decision trees, strengthening the case for AI at the front door of care. Patient pull is strong, with tens of millions already using general-purpose AI for medical queries. Concerns around accuracy, liability and clinical accountability remain unresolved, and 2026 is framed as an execution year.
Broken clinical workflows are the main failure mode, and AI amplifies inefficiencies when deployed too early. Compliance and system integration are dominant causes of pilot failure in hospitals. Governance gaps in Europe raise risks of uneven care, and consumer AI tools still lack healthcare-grade privacy.
EU Medical Device Regulation reform is seen as a potential unlock for innovation speed by 2026, aiming at faster patient access without compromising safety. Large EU-funded Alzheimer's initiatives signal coordinated investment across diagnosis and treatment, with ACCESS-AD reinforcing a pan-European approach. MedGemma 1.5 also points to stronger foundation models.
How we solve real problems for real clients